Eupraxia Pharmaceuticals, Inc. (EPRX)
6.64
+0.04
(+0.61%)
USD |
NASDAQ |
Nov 06, 10:10
Eupraxia Pharmaceuticals Price : 6.64 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 6.77 | 6.87 | 6.30 | 6.60 | 789539.0 |
| Nov 04, 2026 | 7.04 | 7.04 | 6.60 | 6.76 | 660269.0 |
| Nov 03, 2026 | 6.83 | 7.07 | 6.74 | 6.88 | 459248.0 |
| Nov 02, 2026 | 6.92 | 6.96 | 6.64 | 6.76 | 344312.0 |
| Oct 30, 2026 | 7.10 | 7.10 | 6.41 | 6.83 | 1.223M |
| Oct 29, 2026 | 7.44 | 7.51 | 7.10 | 7.25 | 1.015M |
| Oct 28, 2026 | 7.08 | 7.42 | 6.90 | 7.38 | 419991.0 |
| Oct 27, 2026 | 6.90 | 7.16 | 6.64 | 7.08 | 486205.0 |
| Oct 26, 2026 | 6.81 | 7.00 | 6.695 | 6.85 | 540288.0 |
| Oct 23, 2026 | 7.51 | 7.61 | 6.70 | 6.87 | 348797.0 |
| Oct 22, 2026 | 7.70 | 7.94 | 7.545 | 7.59 | 391893.0 |
| Oct 21, 2026 | 7.65 | 7.76 | 7.55 | 7.73 | 348317.0 |
| Oct 20, 2026 | 6.87 | 7.76 | 6.87 | 7.59 | 938688.0 |
| Oct 19, 2026 | 6.67 | 7.05 | 6.67 | 6.95 | 398525.0 |
| Oct 16, 2026 | 6.78 | 6.88 | 6.56 | 6.62 | 582908.0 |
| Oct 15, 2026 | 6.60 | 6.82 | 6.49 | 6.77 | 594850.0 |
| Oct 14, 2026 | 6.59 | 6.805 | 6.42 | 6.59 | 278228.0 |
| Oct 13, 2026 | 7.29 | 7.29 | 6.62 | 6.68 | 1.523M |
| Oct 12, 2026 | 7.46 | 7.56 | 7.250 | 7.32 | 250665.0 |
| Oct 09, 2026 | 7.57 | 7.70 | 7.275 | 7.46 | 1.052M |
| Oct 08, 2026 | 7.69 | 7.75 | 7.34 | 7.57 | 637045.0 |
| Oct 07, 2026 | 7.64 | 7.88 | 7.475 | 7.78 | 853311.0 |
| Oct 06, 2026 | 7.81 | 8.07 | 7.67 | 7.74 | 1.636M |
| Oct 05, 2026 | 7.20 | 7.93 | 7.07 | 7.745 | 1.775M |
| Oct 02, 2026 | 8.00 | 8.09 | 7.19 | 7.24 | 1.714M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Edesa Biotech, Inc. | 2.13 |
| ProMIS Neurosciences, Inc. | 4.00 |
| Arrowhead Pharmaceuticals, Inc. | 57.63 |
| Oncolytics Biotech, Inc. | 0.4545 |
| Sangamo Therapeutics, Inc. | 0.114 |
Price Related Metrics
| PEG Ratio | -0.4106 |
| Price to Book Value | 4.273 |
| Earnings Yield | -14.83% |
| Market Cap | 434.75M |
| PEGY Ratio | -0.4106 |